See more : PT Kobexindo Tractors Tbk (KOBX.JK) Income Statement Analysis – Financial Results
Complete financial analysis of EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (ECILC.IS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- SEED Co.,Ltd. (7743.T) Income Statement Analysis – Financial Results
- VZ Holding AG (VZN.SW) Income Statement Analysis – Financial Results
- Hankook & Company Co., Ltd. (000240.KS) Income Statement Analysis – Financial Results
- WEG S.A. (WEGZY) Income Statement Analysis – Financial Results
- Future Vision II Acquisition Corp. (FVNNR) Income Statement Analysis – Financial Results
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (ECILC.IS)
Industry: Drug Manufacturers - General
Sector: Healthcare
Website: https://www.eczacibasi.com.tr/en/eczacibasi-gruop/companies/other-products-and-services
About EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses primarily in Turkey. The company's Health segment produces and sells human health and veterinary medicines. Its Real Estate Development segment develops real estate properties; and provides consulting services regarding land development and project management. The company was incorporated in 1951 and is based in Istanbul, Turkey. EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a subsidiary of Eczacibasi Holding A.S.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.48B | 1.83B | 1.10B | 909.13M | 877.08M | 692.09M | 597.91M | 1.41B | 1.17B | 1.05B | 1.13B | 1.09B | 973.55M | 913.21M | 874.70M | 805.31M | 921.80M | 996.32M | 847.86M | 847.77M |
| Cost of Revenue | 4.29B | 1.17B | 762.14M | 608.46M | 561.26M | 447.69M | 363.48M | 1.06B | 907.69M | 856.52M | 919.88M | 828.20M | 712.13M | 646.72M | 628.72M | 586.66M | 626.30M | 639.53M | 571.04M | 556.11M |
| Gross Profit | 2.19B | 664.01M | 341.38M | 300.67M | 315.81M | 244.40M | 234.43M | 356.46M | 262.88M | 190.26M | 206.13M | 259.07M | 261.42M | 266.49M | 245.98M | 218.65M | 295.50M | 356.79M | 276.81M | 291.66M |
| Gross Profit Ratio | 33.76% | 36.27% | 30.94% | 33.07% | 36.01% | 35.31% | 39.21% | 25.23% | 22.46% | 18.18% | 18.31% | 23.83% | 26.85% | 29.18% | 28.12% | 27.15% | 32.06% | 35.81% | 32.65% | 34.40% |
| Research & Development | 104.58M | 5.95M | 2.08M | 1.77M | 3.36M | 1.17M | 1.31M | 1.85M | 1.36M | 1.10M | 1.05M | 704.00K | 139.00K | 16.00K | 191.00K | 458.71K | 4.07M | 7.26M | 7.41M | 5.78M |
| General & Administrative | 341.47M | 74.03M | 33.56M | 28.30M | 20.96M | 16.09M | 18.28M | 28.36M | 26.27M | 25.27M | 23.16M | 50.03M | 101.10M | 91.02M | 86.82M | 83.17M | 109.43M | 100.45M | 89.32M | 0.00 |
| Selling & Marketing | 523.23M | 181.85M | 84.84M | 54.12M | 61.45M | 61.55M | 59.25M | 116.43M | 87.50M | 71.83M | 62.10M | 84.22M | 136.49M | 132.56M | 132.02M | 130.96M | 170.47M | 182.39M | 153.66M | 0.00 |
| SG&A | 1.62B | 255.88M | 118.40M | 82.41M | 82.41M | 77.65M | 77.53M | 144.78M | 113.77M | 97.10M | 85.26M | 134.25M | 237.59M | 223.58M | 218.84M | 214.13M | 279.91M | 282.84M | 242.98M | 0.00 |
| Other Expenses | -3.55B | 11.42M | 3.24M | 4.62M | 16.67M | -22.23M | -6.52M | -9.68M | -13.70M | 0.00 | 0.00 | 600.00K | 0.00 | 0.00 | 0.00 | 0.00 | 471.45M | 25.74M | 17.73M | 0.00 |
| Operating Expenses | -1.70B | 476.30M | 254.80M | 185.29M | 190.49M | 192.03M | 178.84M | 310.24M | 258.35M | 205.74M | 196.62M | 263.95M | 250.72M | 215.78M | 230.53M | 222.23M | 283.97M | 290.10M | 250.39M | 142.62M |
| Cost & Expenses | 2.61B | 1.64B | 1.02B | 793.75M | 751.75M | 639.73M | 542.31M | 1.37B | 1.17B | 1.06B | 1.12B | 1.09B | 962.85M | 862.50M | 859.26M | 808.89M | 910.27M | 929.63M | 821.43M | 698.73M |
| Interest Income | 252.20M | 114.62M | 58.04M | 43.07M | 56.97M | 57.76M | 33.26M | 39.47M | 31.89M | 33.80M | 38.88M | 40.18M | 42.26M | 32.07M | 26.93M | 354.42M | 132.60M | -11.45M | 0.00 | 0.00 |
| Interest Expense | 835.15M | 79.64M | 28.92M | 25.45M | 30.78M | 20.12M | 8.74M | 32.41M | 33.00M | 21.33M | 12.48M | 11.29M | 2.43M | 5.37M | -282.47M | 272.85M | 126.43M | 19.01M | 0.00 | 38.22M |
| Depreciation & Amortization | 510.91M | 64.59M | 19.53M | 23.29M | 21.36M | 10.34M | 10.33M | 8.63M | 17.81M | 19.41M | 14.20M | 20.52M | 20.66M | 19.34M | 20.28M | 18.66M | 27.81M | 34.83M | 30.51M | 86.05M |
| EBITDA | 4.41B | 4.78B | 1.54B | 423.69M | 308.42M | 313.51M | 302.99M | 250.09M | 114.14M | 4.66M | 157.22M | 76.12M | 160.33M | 70.05M | 35.73M | 14.81M | 535.45M | 101.52M | 56.93M | 149.03M |
| EBITDA Ratio | 68.05% | 205.81% | 84.76% | 45.26% | 29.68% | 44.83% | 21.31% | 17.28% | 11.20% | -0.85% | 10.52% | 8.76% | 3.22% | 7.67% | 4.08% | 47.22% | 4.27% | 10.19% | 6.71% | 17.58% |
| Operating Income | 3.87B | 687.08M | 691.05M | 297.21M | 224.91M | 208.36M | 129.06M | 154.91M | 123.78M | 18.51M | 134.68M | 22.27M | 10.70M | 50.71M | 15.44M | -3.58M | 11.53M | 66.69M | 26.42M | 62.99M |
| Operating Income Ratio | 59.66% | 37.53% | 62.62% | 32.69% | 25.64% | 30.11% | 21.59% | 10.97% | 10.57% | 1.77% | 11.96% | 2.05% | 1.10% | 5.55% | 1.77% | -0.44% | 1.25% | 6.69% | 3.12% | 7.43% |
| Total Other Income/Expenses | -763.45M | -641.74M | 1.40M | 88.76M | -73.11M | 9.29M | 11.11M | 70.70M | -25.43M | -13.27M | -6.20M | 22.05M | 127.48M | 26.71M | 299.37M | 89.41M | 9.19M | -6.44M | 17.76M | 4.64M |
| Income Before Tax | 3.10B | 4.58B | 939.48M | 385.97M | 193.12M | 295.25M | 170.88M | 197.19M | 73.65M | -50.85M | 87.03M | 44.64M | 121.20M | 78.19M | 319.03M | 88.75M | 481.76M | 61.97M | 44.18M | 0.00 |
| Income Before Tax Ratio | 47.88% | 250.11% | 85.14% | 42.45% | 22.02% | 42.66% | 28.58% | 13.96% | 6.29% | -4.86% | 7.73% | 4.11% | 12.45% | 8.56% | 36.47% | 11.02% | 52.26% | 6.22% | 5.21% | 0.00% |
| Income Tax Expense | 362.21M | 400.49M | 184.41M | 63.85M | 30.39M | 55.16M | 28.14M | 29.63M | 18.67M | 10.39M | 29.00M | 9.45M | 30.82M | 15.02M | 26.84M | 18.30M | 27.43M | 18.73M | 4.66M | 16.21M |
| Net Income | 2.74B | 4.18B | 755.06M | 322.09M | 162.73M | 240.12M | 146.10M | 184.80M | 67.65M | -43.29M | 61.41M | 32.69M | 88.51M | 60.38M | 290.25M | 72.41M | 454.33M | 43.24M | 39.52M | 46.78M |
| Net Income Ratio | 42.28% | 228.22% | 68.42% | 35.43% | 18.55% | 34.69% | 24.43% | 13.08% | 5.78% | -4.14% | 5.45% | 3.01% | 9.09% | 6.61% | 33.18% | 8.99% | 49.29% | 4.34% | 4.66% | 5.52% |
| EPS | 4.00 | 6.10 | 1.10 | 0.47 | 0.24 | 0.35 | 0.21 | 0.27 | 0.11 | -0.06 | 0.09 | 0.05 | 0.13 | 0.09 | 0.42 | 0.11 | 0.66 | 0.06 | 0.06 | 0.07 |
| EPS Diluted | 4.00 | 6.10 | 1.10 | 0.47 | 0.24 | 0.35 | 0.21 | 0.27 | 0.11 | -0.06 | 0.09 | 0.05 | 0.13 | 0.09 | 0.42 | 0.11 | 0.66 | 0.06 | 0.06 | 0.07 |
| Weighted Avg Shares Out | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 675.47M | 607.54M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M |
| Weighted Avg Shares Out (Dil) | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 675.47M | 607.54M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M | 685.26M |
Source: https://incomestatements.info
Category: Stock Reports